Drugs / PH3
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT01068041 Comparator | Aug 2010 → Jul 2014 | diabetic kidney disease | PhytoHealth Corporation | Completed | No outcome recorded |
| Phase 2 | NCT00693667 Comparator | Feb 2008 → Jul 2011 | osteoporosis | PhytoHealth Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PH3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00693667 ↗ |
| Route | Oral | “Three tablets per day will be taken orally before bedtime.” NCT00693667 ↗ |